Todd Binder

Amministratore Delegato presso Neuvogen, Inc.

Provenienza dei contatti di primo grado di Todd Binder

Entità	Tipo di entità	Settore Industriale
Neuvogen, Inc. 4	Private Company		4

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Todd Binder tramite i suoi contatti personali

Società	Settore	Persone collegate	Posizione principale
AMGEN INC.	Pharmaceuticals: Major	Gordon Binder Denny Lanfear	Chief Executive Officer Corporate Officer/Principal
BAXTER INTERNATIONAL INC.	Medical Specialties	Denny Lanfear	Corporate Officer/Principal
FORD MOTOR COMPANY	Motor Vehicles	Gordon Binder	Director of Finance/CFO
Immunex Corp. Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation	Biotechnology	Kendall Mohler	Corporate Officer/Principal
REGENERON PHARMACEUTICALS, INC.	Pharmaceuticals: Major	Denny Lanfear	Corporate Officer/Principal
INSMED INCORPORATED	Pharmaceuticals: Major	Denny Lanfear	Director/Board Member
ACADIA PHARMACEUTICALS INC.	Pharmaceuticals: Major	Gordon Binder	Director/Board Member
Emergent Product Development Seattle Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA.	Pharmaceuticals: Major	Kendall Mohler	Private Equity Investor
ANTHERA PHARMACEUTICALS, INC.	Pharmaceuticals: Major	Denny Lanfear	Director/Board Member
InteKrin Therapeutics, Inc. InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA.	Pharmaceuticals: Major	Denny Lanfear	Founder
Biotechnology Innovation Organization Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.	Miscellaneous Commercial Services	Gordon Binder	Chairman
ZetaRx Biosciences, Inc. ZetaRx Biosciences, Inc. BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., ZetaRx Biosciences, Inc. is a company that develops therapies for the treatment of cancers and other diseases. The company is based in Seattle, WA. The company was founded by Jack Kavanaugh. ZetaRx Biosciences was acquired by Juno Therapeutics, Inc., part of Bristol Myers Squibb Co. from March 07, 2018 on October 31, 2013 for $8.40 million.	Biotechnology	Kendall Mohler	Chief Tech/Sci/R&D Officer
Michigan State University	College/University	Denny Lanfear	Undergraduate Degree
Harvard University Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.	College/University	Gordon Binder	Masters Business Admin
Massachusetts Institute of Technology	College/University	Gordon Binder	Director/Board Member
The University of Texas at Austin	College/University	Kendall Mohler	Doctorate Degree
Yale University	College/University	Mark W. Frohlich	Undergraduate Degree
California Institute of Technology California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.	College/University	Gordon Binder	Director/Board Member
Pepperdine University	College/University	Gordon Binder	Director/Board Member
Purdue University	College/University	Gordon Binder	Undergraduate Degree
University of Kansas	College/University	Kendall Mohler	Undergraduate Degree
The University of California, San Francisco	College/University	Mark W. Frohlich	Corporate Officer/Principal
Gilead Connecticut, Inc. Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA.	Pharmaceuticals: Major	Gordon Binder	Director/Board Member
SKB Corp. SKB Corp. Miscellaneous ManufacturingProducer Manufacturing SKB Corp. manufactures cases for musical instruments. Its products include guitars, drums, keyboards, racks and rigs and pedalboards. The firm provides services to the music, industrial and sports industries. The company was founded by Steve Kottman and Dave Sanderson in 1977 and is headquartered in Orange, CA.	Miscellaneous Manufacturing	Denny Lanfear	Corporate Officer/Principal
Pearl Street Venture Funds Pearl Street Venture Funds Investment ManagersFinance Pearl Street Venture Funds (Pearl Street) is a venture capital firm founded in 2003 by Tim J. Tichenor. The firm is headquartered in Indianapolis, Indiana.	Investment Managers	Gordon Binder	Private Equity Investor
Pharmaceutical Research & Manufacturers of America Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.	Pharmaceuticals: Major	Gordon Binder	Chairman
Accelerator Services Corp Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington.	Investment Managers	Kendall Mohler	Corporate Officer/Principal
American Enterprise Institute for Public Policy Research American Enterprise Institute for Public Policy Research Miscellaneous Commercial ServicesCommercial Services American Enterprise Institute for Public Policy Research provides industrial design services. AEI produces articles from economics, law, political science, defense and foreign policy studies, ethics, theology, health care, and other fields. The company was founded in 1938 and is headquartered in Washington, DC.	Miscellaneous Commercial Services	Gordon Binder	Director/Board Member
System Development Corp.		Gordon Binder	Director of Finance/CFO
Harvard Medical School	College/University	Mark W. Frohlich	Doctorate Degree
COHERUS BIOSCIENCES, INC.	Pharmaceuticals: Major	Denny Lanfear	Chief Executive Officer
Harvard Business School	College/University	Gordon Binder	Masters Business Admin
JUNO THERAPEUTICS INC	Biotechnology	Mark W. Frohlich Kendall Mohler	Corporate Officer/Principal Chief Tech/Sci/R&D Officer
Anderson School of Management	College/University	Denny Lanfear	Masters Business Admin
BioEclipse Therapeutics, Inc. BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA.	Pharmaceuticals: Major	Mark W. Frohlich	Director/Board Member
Indapta Therapeutics, Inc. Indapta Therapeutics, Inc. BiotechnologyHealth Technology Indapta Therapeutics, Inc. operates as a biotechnology company. It focuses on developing and commercializing a proprietary, first-in-class, off-the-shelf allogeneic cell therapy to treat multiple types of difficult-to-treat hematologic cancers and solid tumors. The company was founded by Guy DiPierro, Ronald A. Martell, Sungjin Kim and John Sunwoo in 2017 and is headquartered in Houston, TX.	Biotechnology	Mark W. Frohlich	Chief Executive Officer
HUMACYTE, INC.	Biotechnology	Gordon Binder	Director/Board Member
ALSP ORCHID ACQUISITION CORPORATION I	Financial Conglomerates	Kendall Mohler	Corporate Officer/Principal
X-Chem, Inc. (Massachusetts) X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA.	Packaged Software	Gordon Binder	Founder